nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR7—epilepsy syndrome	0.315	0.665	CbGaD
Methysergide—HTR2A—epilepsy syndrome	0.159	0.335	CbGaD
Methysergide—HTR1D—meninx—epilepsy syndrome	0.0115	0.0957	CbGeAlD
Methysergide—HTR2A—phrenic nerve—epilepsy syndrome	0.00621	0.0515	CbGeAlD
Methysergide—HTR7—locus ceruleus—epilepsy syndrome	0.00445	0.0369	CbGeAlD
Methysergide—HTR1F—ganglion—epilepsy syndrome	0.00415	0.0344	CbGeAlD
Methysergide—HTR7—vagus nerve—epilepsy syndrome	0.0034	0.0282	CbGeAlD
Methysergide—HTR6—ganglion—epilepsy syndrome	0.00282	0.0234	CbGeAlD
Methysergide—HTR2A—locus ceruleus—epilepsy syndrome	0.00277	0.023	CbGeAlD
Methysergide—HTR1B—telencephalic ventricle—epilepsy syndrome	0.00273	0.0227	CbGeAlD
Methysergide—HTR1D—telencephalic ventricle—epilepsy syndrome	0.00265	0.0219	CbGeAlD
Methysergide—HTR2C—telencephalic ventricle—epilepsy syndrome	0.00262	0.0217	CbGeAlD
Methysergide—HTR7—pons—epilepsy syndrome	0.00256	0.0212	CbGeAlD
Methysergide—HTR7—autonomic nervous system—epilepsy syndrome	0.00236	0.0196	CbGeAlD
Methysergide—HTR2A—cerebellar cortex—epilepsy syndrome	0.00226	0.0187	CbGeAlD
Methysergide—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00221	0.0183	CbGeAlD
Methysergide—HTR2A—vagus nerve—epilepsy syndrome	0.00212	0.0176	CbGeAlD
Methysergide—HTR7—telencephalic ventricle—epilepsy syndrome	0.00211	0.0175	CbGeAlD
Methysergide—HTR1F—forebrain—epilepsy syndrome	0.00174	0.0144	CbGeAlD
Methysergide—HTR1B—ganglion—epilepsy syndrome	0.0017	0.0141	CbGeAlD
Methysergide—HTR1D—ganglion—epilepsy syndrome	0.00165	0.0137	CbGeAlD
Methysergide—HTR2C—ganglion—epilepsy syndrome	0.00163	0.0135	CbGeAlD
Methysergide—HTR1F—telencephalon—epilepsy syndrome	0.0016	0.0133	CbGeAlD
Methysergide—HTR2A—pons—epilepsy syndrome	0.0016	0.0132	CbGeAlD
Methysergide—HTR1E—brainstem—epilepsy syndrome	0.00156	0.013	CbGeAlD
Methysergide—HTR1E—forebrain—epilepsy syndrome	0.00151	0.0125	CbGeAlD
Methysergide—HTR2A—autonomic nervous system—epilepsy syndrome	0.00147	0.0122	CbGeAlD
Methysergide—HTR1E—telencephalon—epilepsy syndrome	0.00139	0.0115	CbGeAlD
Methysergide—HTR1A—ganglion—epilepsy syndrome	0.00137	0.0114	CbGeAlD
Methysergide—HTR2A—telencephalic ventricle—epilepsy syndrome	0.00132	0.0109	CbGeAlD
Methysergide—HTR7—ganglion—epilepsy syndrome	0.00131	0.0109	CbGeAlD
Methysergide—HTR6—forebrain—epilepsy syndrome	0.00118	0.00982	CbGeAlD
Methysergide—Nicergoline—CYP2D6—epilepsy syndrome	0.00111	0.242	CrCbGaD
Methysergide—HTR6—telencephalon—epilepsy syndrome	0.00109	0.00903	CbGeAlD
Methysergide—HTR1A—hindbrain—epilepsy syndrome	0.00104	0.00863	CbGeAlD
Methysergide—HTR1F—head—epilepsy syndrome	0.000998	0.00827	CbGeAlD
Methysergide—HTR7—hindbrain—epilepsy syndrome	0.000996	0.00825	CbGeAlD
Methysergide—HTR1F—nervous system—epilepsy syndrome	0.000946	0.00784	CbGeAlD
Methysergide—HTR1F—central nervous system—epilepsy syndrome	0.000911	0.00755	CbGeAlD
Methysergide—HTR1E—head—epilepsy syndrome	0.000864	0.00717	CbGeAlD
Methysergide—HTR1E—nervous system—epilepsy syndrome	0.00082	0.00679	CbGeAlD
Methysergide—HTR2A—ganglion—epilepsy syndrome	0.000819	0.00679	CbGeAlD
Methysergide—HTR1E—central nervous system—epilepsy syndrome	0.000789	0.00654	CbGeAlD
Methysergide—HTR1B—brainstem—epilepsy syndrome	0.00074	0.00613	CbGeAlD
Methysergide—HTR1F—brain—epilepsy syndrome	0.000723	0.00599	CbGeAlD
Methysergide—HTR1D—brainstem—epilepsy syndrome	0.000716	0.00594	CbGeAlD
Methysergide—HTR1B—forebrain—epilepsy syndrome	0.000714	0.00592	CbGeAlD
Methysergide—HTR2C—brainstem—epilepsy syndrome	0.000709	0.00588	CbGeAlD
Methysergide—HTR1D—forebrain—epilepsy syndrome	0.000691	0.00573	CbGeAlD
Methysergide—HTR2C—forebrain—epilepsy syndrome	0.000685	0.00567	CbGeAlD
Methysergide—HTR6—head—epilepsy syndrome	0.000678	0.00562	CbGeAlD
Methysergide—HTR1B—telencephalon—epilepsy syndrome	0.000657	0.00544	CbGeAlD
Methysergide—HTR6—nervous system—epilepsy syndrome	0.000643	0.00533	CbGeAlD
Methysergide—HTR2B—forebrain—epilepsy syndrome	0.000643	0.00533	CbGeAlD
Methysergide—HTR1D—telencephalon—epilepsy syndrome	0.000636	0.00527	CbGeAlD
Methysergide—HTR2C—telencephalon—epilepsy syndrome	0.00063	0.00522	CbGeAlD
Methysergide—HTR1E—brain—epilepsy syndrome	0.000626	0.00519	CbGeAlD
Methysergide—HTR2A—hindbrain—epilepsy syndrome	0.000621	0.00515	CbGeAlD
Methysergide—HTR6—central nervous system—epilepsy syndrome	0.000619	0.00513	CbGeAlD
Methysergide—HTR1A—brainstem—epilepsy syndrome	0.000597	0.00495	CbGeAlD
Methysergide—SIGMAR1—telencephalon—epilepsy syndrome	0.000593	0.00491	CbGeAlD
Methysergide—HTR2B—telencephalon—epilepsy syndrome	0.000591	0.0049	CbGeAlD
Methysergide—HTR1A—forebrain—epilepsy syndrome	0.000576	0.00478	CbGeAlD
Methysergide—HTR7—brainstem—epilepsy syndrome	0.000571	0.00473	CbGeAlD
Methysergide—HTR7—forebrain—epilepsy syndrome	0.000551	0.00456	CbGeAlD
Methysergide—HTR1A—telencephalon—epilepsy syndrome	0.00053	0.00439	CbGeAlD
Methysergide—HTR7—telencephalon—epilepsy syndrome	0.000506	0.0042	CbGeAlD
Methysergide—HTR2C—medulla oblongata—epilepsy syndrome	0.000495	0.0041	CbGeAlD
Methysergide—HTR6—brain—epilepsy syndrome	0.000492	0.00407	CbGeAlD
Methysergide—HTR1B—midbrain—epilepsy syndrome	0.000472	0.00391	CbGeAlD
Methysergide—SIGMAR1—medulla oblongata—epilepsy syndrome	0.000466	0.00386	CbGeAlD
Methysergide—HTR1B—spinal cord—epilepsy syndrome	0.00046	0.00381	CbGeAlD
Methysergide—HTR1D—midbrain—epilepsy syndrome	0.000457	0.00378	CbGeAlD
Methysergide—HTR2C—midbrain—epilepsy syndrome	0.000452	0.00375	CbGeAlD
Methysergide—Bromocriptine—HTR7—epilepsy syndrome	0.000444	0.0969	CrCbGaD
Methysergide—HTR2C—spinal cord—epilepsy syndrome	0.000441	0.00366	CbGeAlD
Methysergide—SIGMAR1—midbrain—epilepsy syndrome	0.000426	0.00353	CbGeAlD
Methysergide—SIGMAR1—spinal cord—epilepsy syndrome	0.000415	0.00344	CbGeAlD
Methysergide—Lisuride—ADRA2A—epilepsy syndrome	0.000411	0.0897	CrCbGaD
Methysergide—HTR1B—head—epilepsy syndrome	0.000409	0.00339	CbGeAlD
Methysergide—HTR7—medulla oblongata—epilepsy syndrome	0.000398	0.0033	CbGeAlD
Methysergide—HTR1D—head—epilepsy syndrome	0.000396	0.00328	CbGeAlD
Methysergide—Ergotamine—ADRA2A—epilepsy syndrome	0.000395	0.0862	CrCbGaD
Methysergide—HTR2C—head—epilepsy syndrome	0.000392	0.00325	CbGeAlD
Methysergide—HTR1B—nervous system—epilepsy syndrome	0.000388	0.00321	CbGeAlD
Methysergide—Bromocriptine—ADRA2A—epilepsy syndrome	0.000381	0.0831	CrCbGaD
Methysergide—HTR1A—midbrain—epilepsy syndrome	0.000381	0.00315	CbGeAlD
Methysergide—HTR1D—nervous system—epilepsy syndrome	0.000375	0.00311	CbGeAlD
Methysergide—HTR1B—central nervous system—epilepsy syndrome	0.000373	0.00309	CbGeAlD
Methysergide—HTR2C—nervous system—epilepsy syndrome	0.000372	0.00308	CbGeAlD
Methysergide—HTR1A—spinal cord—epilepsy syndrome	0.000371	0.00308	CbGeAlD
Methysergide—HTR2B—head—epilepsy syndrome	0.000368	0.00305	CbGeAlD
Methysergide—HTR7—midbrain—epilepsy syndrome	0.000364	0.00301	CbGeAlD
Methysergide—HTR1D—central nervous system—epilepsy syndrome	0.000361	0.00299	CbGeAlD
Methysergide—Methylergometrine—HTR2A—epilepsy syndrome	0.000359	0.0784	CrCbGaD
Methysergide—HTR2C—central nervous system—epilepsy syndrome	0.000358	0.00297	CbGeAlD
Methysergide—HTR2A—brainstem—epilepsy syndrome	0.000356	0.00295	CbGeAlD
Methysergide—HTR7—spinal cord—epilepsy syndrome	0.000355	0.00294	CbGeAlD
Methysergide—HTR2B—nervous system—epilepsy syndrome	0.000349	0.00289	CbGeAlD
Methysergide—HTR2A—forebrain—epilepsy syndrome	0.000343	0.00285	CbGeAlD
Methysergide—HTR2B—central nervous system—epilepsy syndrome	0.000336	0.00279	CbGeAlD
Methysergide—HTR1A—head—epilepsy syndrome	0.00033	0.00273	CbGeAlD
Methysergide—SIGMAR1—cerebellum—epilepsy syndrome	0.000329	0.00273	CbGeAlD
Methysergide—HTR2A—telencephalon—epilepsy syndrome	0.000316	0.00262	CbGeAlD
Methysergide—HTR7—head—epilepsy syndrome	0.000315	0.00261	CbGeAlD
Methysergide—HTR1A—nervous system—epilepsy syndrome	0.000313	0.00259	CbGeAlD
Methysergide—HTR1A—central nervous system—epilepsy syndrome	0.000301	0.0025	CbGeAlD
Methysergide—HTR7—nervous system—epilepsy syndrome	0.000299	0.00248	CbGeAlD
Methysergide—HTR1B—brain—epilepsy syndrome	0.000296	0.00246	CbGeAlD
Methysergide—HTR1A—cerebellum—epilepsy syndrome	0.000294	0.00244	CbGeAlD
Methysergide—HTR7—central nervous system—epilepsy syndrome	0.000288	0.00239	CbGeAlD
Methysergide—HTR1D—brain—epilepsy syndrome	0.000287	0.00238	CbGeAlD
Methysergide—HTR2C—brain—epilepsy syndrome	0.000284	0.00235	CbGeAlD
Methysergide—HTR7—cerebellum—epilepsy syndrome	0.000281	0.00233	CbGeAlD
Methysergide—Ergonovine—ABCB1—epilepsy syndrome	0.000268	0.0586	CrCbGaD
Methysergide—SIGMAR1—brain—epilepsy syndrome	0.000267	0.00222	CbGeAlD
Methysergide—HTR2B—brain—epilepsy syndrome	0.000267	0.00221	CbGeAlD
Methysergide—HTR2A—medulla oblongata—epilepsy syndrome	0.000248	0.00206	CbGeAlD
Methysergide—Lisuride—HTR2A—epilepsy syndrome	0.000241	0.0526	CrCbGaD
Methysergide—HTR1A—brain—epilepsy syndrome	0.000239	0.00198	CbGeAlD
Methysergide—Ergotamine—HTR2A—epilepsy syndrome	0.000231	0.0505	CrCbGaD
Methysergide—HTR7—brain—epilepsy syndrome	0.000229	0.00189	CbGeAlD
Methysergide—HTR2A—midbrain—epilepsy syndrome	0.000227	0.00188	CbGeAlD
Methysergide—Bromocriptine—HTR2A—epilepsy syndrome	0.000223	0.0487	CrCbGaD
Methysergide—HTR2A—spinal cord—epilepsy syndrome	0.000221	0.00183	CbGeAlD
Methysergide—Lisuride—CYP2D6—epilepsy syndrome	0.00022	0.0481	CrCbGaD
Methysergide—HTR2A—head—epilepsy syndrome	0.000197	0.00163	CbGeAlD
Methysergide—HTR2A—nervous system—epilepsy syndrome	0.000186	0.00155	CbGeAlD
Methysergide—HTR2A—central nervous system—epilepsy syndrome	0.000179	0.00149	CbGeAlD
Methysergide—HTR2A—cerebellum—epilepsy syndrome	0.000175	0.00145	CbGeAlD
Methysergide—Feeling abnormal—Clonazepam—epilepsy syndrome	0.000169	0.00073	CcSEcCtD
Methysergide—Paraesthesia—Lamotrigine—epilepsy syndrome	0.000169	0.000729	CcSEcCtD
Methysergide—Abdominal pain—Zonisamide—epilepsy syndrome	0.000169	0.000726	CcSEcCtD
Methysergide—Body temperature increased—Zonisamide—epilepsy syndrome	0.000169	0.000726	CcSEcCtD
Methysergide—Asthenia—Fosphenytoin—epilepsy syndrome	0.000168	0.000725	CcSEcCtD
Methysergide—Alopecia—Pregabalin—epilepsy syndrome	0.000168	0.000725	CcSEcCtD
Methysergide—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000168	0.000725	CcSEcCtD
Methysergide—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000168	0.000725	CcSEcCtD
Methysergide—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000168	0.000724	CcSEcCtD
Methysergide—Fatigue—Carbamazepine—epilepsy syndrome	0.000168	0.000724	CcSEcCtD
Methysergide—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000168	0.000723	CcSEcCtD
Methysergide—Somnolence—Lamotrigine—epilepsy syndrome	0.000168	0.000721	CcSEcCtD
Methysergide—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000167	0.000721	CcSEcCtD
Methysergide—Weight increased—Topiramate—epilepsy syndrome	0.000167	0.00072	CcSEcCtD
Methysergide—Pain—Carbamazepine—epilepsy syndrome	0.000167	0.000718	CcSEcCtD
Methysergide—Constipation—Carbamazepine—epilepsy syndrome	0.000167	0.000718	CcSEcCtD
Methysergide—Dizziness—Propofol—epilepsy syndrome	0.000166	0.000717	CcSEcCtD
Methysergide—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000166	0.000716	CcSEcCtD
Methysergide—Weight decreased—Topiramate—epilepsy syndrome	0.000166	0.000715	CcSEcCtD
Methysergide—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000166	0.000715	CcSEcCtD
Methysergide—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000166	0.000714	CcSEcCtD
Methysergide—Malaise—Valproic Acid—epilepsy syndrome	0.000165	0.000712	CcSEcCtD
Methysergide—Asthenia—Vigabatrin—epilepsy syndrome	0.000164	0.000707	CcSEcCtD
Methysergide—Dizziness—Midazolam—epilepsy syndrome	0.000163	0.000701	CcSEcCtD
Methysergide—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000163	0.0007	CcSEcCtD
Methysergide—Body temperature increased—Clonazepam—epilepsy syndrome	0.000163	0.0007	CcSEcCtD
Methysergide—Abdominal pain—Clonazepam—epilepsy syndrome	0.000163	0.0007	CcSEcCtD
Methysergide—Fatigue—Lamotrigine—epilepsy syndrome	0.000162	0.000699	CcSEcCtD
Methysergide—Asthenia—Diazepam—epilepsy syndrome	0.000162	0.000696	CcSEcCtD
Methysergide—Body temperature increased—Phenytoin—epilepsy syndrome	0.000161	0.000695	CcSEcCtD
Methysergide—Constipation—Lamotrigine—epilepsy syndrome	0.000161	0.000694	CcSEcCtD
Methysergide—Pain—Lamotrigine—epilepsy syndrome	0.000161	0.000694	CcSEcCtD
Methysergide—Nausea—Acetazolamide—epilepsy syndrome	0.000161	0.000693	CcSEcCtD
Methysergide—Dizziness—Levetiracetam—epilepsy syndrome	0.000161	0.000692	CcSEcCtD
Methysergide—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000161	0.000692	CcSEcCtD
Methysergide—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000161	0.000692	CcSEcCtD
Methysergide—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000161	0.000692	CcSEcCtD
Methysergide—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000161	0.000691	CcSEcCtD
Methysergide—Back pain—Pregabalin—epilepsy syndrome	0.00016	0.000691	CcSEcCtD
Methysergide—Vomiting—Propofol—epilepsy syndrome	0.00016	0.000689	CcSEcCtD
Methysergide—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000159	0.000686	CcSEcCtD
Methysergide—Rash—Propofol—epilepsy syndrome	0.000159	0.000683	CcSEcCtD
Methysergide—Dermatitis—Propofol—epilepsy syndrome	0.000159	0.000683	CcSEcCtD
Methysergide—Vomiting—Midazolam—epilepsy syndrome	0.000157	0.000674	CcSEcCtD
Methysergide—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000157	0.000674	CcSEcCtD
Methysergide—Asthenia—Felbamate—epilepsy syndrome	0.000156	0.000673	CcSEcCtD
Methysergide—Myalgia—Valproic Acid—epilepsy syndrome	0.000156	0.000673	CcSEcCtD
Methysergide—Chest pain—Valproic Acid—epilepsy syndrome	0.000156	0.000673	CcSEcCtD
Methysergide—Arthralgia—Valproic Acid—epilepsy syndrome	0.000156	0.000673	CcSEcCtD
Methysergide—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000155	0.000669	CcSEcCtD
Methysergide—Rash—Midazolam—epilepsy syndrome	0.000155	0.000668	CcSEcCtD
Methysergide—Dizziness—Fosphenytoin—epilepsy syndrome	0.000155	0.000668	CcSEcCtD
Methysergide—Dermatitis—Midazolam—epilepsy syndrome	0.000155	0.000668	CcSEcCtD
Methysergide—Vomiting—Levetiracetam—epilepsy syndrome	0.000155	0.000666	CcSEcCtD
Methysergide—Alopecia—Gabapentin—epilepsy syndrome	0.000154	0.000665	CcSEcCtD
Methysergide—Discomfort—Valproic Acid—epilepsy syndrome	0.000154	0.000664	CcSEcCtD
Methysergide—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000154	0.000664	CcSEcCtD
Methysergide—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000154	0.000664	CcSEcCtD
Methysergide—Diarrhoea—Diazepam—epilepsy syndrome	0.000154	0.000663	CcSEcCtD
Methysergide—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000154	0.000663	CcSEcCtD
Methysergide—Ill-defined disorder—Pregabalin—epilepsy syndrome	0.000154	0.000663	CcSEcCtD
Methysergide—Rash—Levetiracetam—epilepsy syndrome	0.000153	0.00066	CcSEcCtD
Methysergide—Dermatitis—Levetiracetam—epilepsy syndrome	0.000153	0.00066	CcSEcCtD
Methysergide—Asthenia—Zonisamide—epilepsy syndrome	0.000153	0.000659	CcSEcCtD
Methysergide—Dizziness—Vigabatrin—epilepsy syndrome	0.000151	0.000651	CcSEcCtD
Methysergide—Ergotamine—ABCB1—epilepsy syndrome	0.000151	0.033	CrCbGaD
Methysergide—Oedema—Valproic Acid—epilepsy syndrome	0.00015	0.000645	CcSEcCtD
Methysergide—Malaise—Pregabalin—epilepsy syndrome	0.00015	0.000644	CcSEcCtD
Methysergide—Nausea—Propofol—epilepsy syndrome	0.00015	0.000644	CcSEcCtD
Methysergide—Vomiting—Fosphenytoin—epilepsy syndrome	0.000149	0.000642	CcSEcCtD
Methysergide—Diarrhoea—Felbamate—epilepsy syndrome	0.000149	0.000642	CcSEcCtD
Methysergide—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000149	0.000641	CcSEcCtD
Methysergide—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000149	0.000641	CcSEcCtD
Methysergide—Dizziness—Diazepam—epilepsy syndrome	0.000149	0.000641	CcSEcCtD
Methysergide—Rash—Fosphenytoin—epilepsy syndrome	0.000148	0.000637	CcSEcCtD
Methysergide—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000148	0.000637	CcSEcCtD
Methysergide—Asthenia—Clonazepam—epilepsy syndrome	0.000148	0.000635	CcSEcCtD
Methysergide—Back pain—Gabapentin—epilepsy syndrome	0.000147	0.000633	CcSEcCtD
Methysergide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000147	0.000631	CcSEcCtD
Methysergide—Asthenia—Phenytoin—epilepsy syndrome	0.000147	0.000631	CcSEcCtD
Methysergide—Nausea—Midazolam—epilepsy syndrome	0.000146	0.00063	CcSEcCtD
Methysergide—Tachycardia—Valproic Acid—epilepsy syndrome	0.000146	0.000629	CcSEcCtD
Methysergide—Diarrhoea—Zonisamide—epilepsy syndrome	0.000146	0.000629	CcSEcCtD
Methysergide—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000146	0.000628	CcSEcCtD
Methysergide—Bromocriptine—ABCB1—epilepsy syndrome	0.000146	0.0318	CrCbGaD
Methysergide—Vomiting—Vigabatrin—epilepsy syndrome	0.000145	0.000626	CcSEcCtD
Methysergide—Oedema peripheral—Topiramate—epilepsy syndrome	0.000145	0.000623	CcSEcCtD
Methysergide—Nausea—Levetiracetam—epilepsy syndrome	0.000144	0.000622	CcSEcCtD
Methysergide—Rash—Vigabatrin—epilepsy syndrome	0.000144	0.000621	CcSEcCtD
Methysergide—Dizziness—Felbamate—epilepsy syndrome	0.000144	0.000621	CcSEcCtD
Methysergide—Dermatitis—Vigabatrin—epilepsy syndrome	0.000144	0.00062	CcSEcCtD
Methysergide—Convulsion—Pregabalin—epilepsy syndrome	0.000144	0.000619	CcSEcCtD
Methysergide—Vomiting—Diazepam—epilepsy syndrome	0.000143	0.000617	CcSEcCtD
Methysergide—HTR2A—brain—epilepsy syndrome	0.000142	0.00118	CbGeAlD
Methysergide—Rash—Diazepam—epilepsy syndrome	0.000142	0.000611	CcSEcCtD
Methysergide—Dermatitis—Diazepam—epilepsy syndrome	0.000142	0.000611	CcSEcCtD
Methysergide—Chest pain—Pregabalin—epilepsy syndrome	0.000141	0.000608	CcSEcCtD
Methysergide—Arthralgia—Pregabalin—epilepsy syndrome	0.000141	0.000608	CcSEcCtD
Methysergide—Myalgia—Pregabalin—epilepsy syndrome	0.000141	0.000608	CcSEcCtD
Methysergide—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000141	0.000608	CcSEcCtD
Methysergide—Dizziness—Zonisamide—epilepsy syndrome	0.000141	0.000607	CcSEcCtD
Methysergide—Diarrhoea—Clonazepam—epilepsy syndrome	0.000141	0.000606	CcSEcCtD
Methysergide—Asthenia—Carbamazepine—epilepsy syndrome	0.00014	0.000602	CcSEcCtD
Methysergide—Diarrhoea—Phenytoin—epilepsy syndrome	0.00014	0.000602	CcSEcCtD
Methysergide—Discomfort—Pregabalin—epilepsy syndrome	0.00014	0.000601	CcSEcCtD
Methysergide—Nausea—Fosphenytoin—epilepsy syndrome	0.000139	0.0006	CcSEcCtD
Methysergide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000139	0.000599	CcSEcCtD
Methysergide—Vomiting—Felbamate—epilepsy syndrome	0.000139	0.000597	CcSEcCtD
Methysergide—Rash—Felbamate—epilepsy syndrome	0.000137	0.000592	CcSEcCtD
Methysergide—Dermatitis—Felbamate—epilepsy syndrome	0.000137	0.000591	CcSEcCtD
Methysergide—Malaise—Gabapentin—epilepsy syndrome	0.000137	0.000591	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000136	0.000587	CcSEcCtD
Methysergide—Flushing—Topiramate—epilepsy syndrome	0.000136	0.000587	CcSEcCtD
Methysergide—Dizziness—Clonazepam—epilepsy syndrome	0.000136	0.000585	CcSEcCtD
Methysergide—Nausea—Vigabatrin—epilepsy syndrome	0.000136	0.000585	CcSEcCtD
Methysergide—Vomiting—Zonisamide—epilepsy syndrome	0.000136	0.000584	CcSEcCtD
Methysergide—Insomnia—Valproic Acid—epilepsy syndrome	0.000135	0.000583	CcSEcCtD
Methysergide—Oedema—Pregabalin—epilepsy syndrome	0.000135	0.000583	CcSEcCtD
Methysergide—Asthenia—Lamotrigine—epilepsy syndrome	0.000135	0.000582	CcSEcCtD
Methysergide—Dizziness—Phenytoin—epilepsy syndrome	0.000135	0.000582	CcSEcCtD
Methysergide—Rash—Zonisamide—epilepsy syndrome	0.000135	0.000579	CcSEcCtD
Methysergide—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000134	0.000579	CcSEcCtD
Methysergide—Dermatitis—Zonisamide—epilepsy syndrome	0.000134	0.000579	CcSEcCtD
Methysergide—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000134	0.000578	CcSEcCtD
Methysergide—Nausea—Diazepam—epilepsy syndrome	0.000134	0.000576	CcSEcCtD
Methysergide—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000134	0.000575	CcSEcCtD
Methysergide—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000133	0.000574	CcSEcCtD
Methysergide—Somnolence—Valproic Acid—epilepsy syndrome	0.000133	0.000573	CcSEcCtD
Methysergide—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000133	0.000571	CcSEcCtD
Methysergide—Tachycardia—Pregabalin—epilepsy syndrome	0.000132	0.000569	CcSEcCtD
Methysergide—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000132	0.000568	CcSEcCtD
Methysergide—Convulsion—Gabapentin—epilepsy syndrome	0.000132	0.000567	CcSEcCtD
Methysergide—Vomiting—Clonazepam—epilepsy syndrome	0.000131	0.000563	CcSEcCtD
Methysergide—Alopecia—Topiramate—epilepsy syndrome	0.00013	0.000559	CcSEcCtD
Methysergide—Vomiting—Phenytoin—epilepsy syndrome	0.00013	0.000559	CcSEcCtD
Methysergide—Rash—Clonazepam—epilepsy syndrome	0.00013	0.000558	CcSEcCtD
Methysergide—Dermatitis—Clonazepam—epilepsy syndrome	0.00013	0.000558	CcSEcCtD
Methysergide—Arthralgia—Gabapentin—epilepsy syndrome	0.00013	0.000558	CcSEcCtD
Methysergide—Chest pain—Gabapentin—epilepsy syndrome	0.00013	0.000558	CcSEcCtD
Methysergide—Myalgia—Gabapentin—epilepsy syndrome	0.00013	0.000558	CcSEcCtD
Methysergide—Nausea—Felbamate—epilepsy syndrome	0.000129	0.000557	CcSEcCtD
Methysergide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000129	0.000557	CcSEcCtD
Methysergide—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000129	0.000556	CcSEcCtD
Methysergide—Fatigue—Valproic Acid—epilepsy syndrome	0.000129	0.000556	CcSEcCtD
Methysergide—Dizziness—Carbamazepine—epilepsy syndrome	0.000129	0.000555	CcSEcCtD
Methysergide—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000129	0.000555	CcSEcCtD
Methysergide—Rash—Phenytoin—epilepsy syndrome	0.000129	0.000555	CcSEcCtD
Methysergide—Dermatitis—Phenytoin—epilepsy syndrome	0.000129	0.000554	CcSEcCtD
Methysergide—Rash—Oxcarbazepine—epilepsy syndrome	0.000128	0.000552	CcSEcCtD
Methysergide—Pain—Valproic Acid—epilepsy syndrome	0.000128	0.000551	CcSEcCtD
Methysergide—Constipation—Valproic Acid—epilepsy syndrome	0.000128	0.000551	CcSEcCtD
Methysergide—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000128	0.000551	CcSEcCtD
Methysergide—Discomfort—Gabapentin—epilepsy syndrome	0.000128	0.000551	CcSEcCtD
Methysergide—Nausea—Zonisamide—epilepsy syndrome	0.000127	0.000546	CcSEcCtD
Methysergide—Dizziness—Lamotrigine—epilepsy syndrome	0.000125	0.000537	CcSEcCtD
Methysergide—Oedema—Gabapentin—epilepsy syndrome	0.000124	0.000534	CcSEcCtD
Methysergide—Vomiting—Carbamazepine—epilepsy syndrome	0.000124	0.000534	CcSEcCtD
Methysergide—Back pain—Topiramate—epilepsy syndrome	0.000124	0.000533	CcSEcCtD
Methysergide—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000123	0.000531	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000123	0.000531	CcSEcCtD
Methysergide—Rash—Carbamazepine—epilepsy syndrome	0.000123	0.000529	CcSEcCtD
Methysergide—Dermatitis—Carbamazepine—epilepsy syndrome	0.000123	0.000529	CcSEcCtD
Methysergide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000122	0.000527	CcSEcCtD
Methysergide—Insomnia—Pregabalin—epilepsy syndrome	0.000122	0.000527	CcSEcCtD
Methysergide—Nausea—Clonazepam—epilepsy syndrome	0.000122	0.000526	CcSEcCtD
Methysergide—Paraesthesia—Pregabalin—epilepsy syndrome	0.000122	0.000523	CcSEcCtD
Methysergide—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000122	0.000523	CcSEcCtD
Methysergide—Nausea—Phenytoin—epilepsy syndrome	0.000121	0.000522	CcSEcCtD
Methysergide—Tachycardia—Gabapentin—epilepsy syndrome	0.000121	0.000522	CcSEcCtD
Methysergide—Dyspnoea—Pregabalin—epilepsy syndrome	0.000121	0.00052	CcSEcCtD
Methysergide—Nausea—Oxcarbazepine—epilepsy syndrome	0.000121	0.00052	CcSEcCtD
Methysergide—Somnolence—Pregabalin—epilepsy syndrome	0.00012	0.000518	CcSEcCtD
Methysergide—Vomiting—Lamotrigine—epilepsy syndrome	0.00012	0.000516	CcSEcCtD
Methysergide—Rash—Lamotrigine—epilepsy syndrome	0.000119	0.000512	CcSEcCtD
Methysergide—Ill-defined disorder—Topiramate—epilepsy syndrome	0.000119	0.000511	CcSEcCtD
Methysergide—Dermatitis—Lamotrigine—epilepsy syndrome	0.000119	0.000511	CcSEcCtD
Methysergide—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000118	0.00051	CcSEcCtD
Methysergide—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000118	0.00051	CcSEcCtD
Methysergide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000117	0.000503	CcSEcCtD
Methysergide—Fatigue—Pregabalin—epilepsy syndrome	0.000117	0.000503	CcSEcCtD
Methysergide—Nausea—Carbamazepine—epilepsy syndrome	0.000116	0.000499	CcSEcCtD
Methysergide—Constipation—Pregabalin—epilepsy syndrome	0.000116	0.000498	CcSEcCtD
Methysergide—Pain—Pregabalin—epilepsy syndrome	0.000116	0.000498	CcSEcCtD
Methysergide—Malaise—Topiramate—epilepsy syndrome	0.000115	0.000497	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000113	0.000487	CcSEcCtD
Methysergide—Insomnia—Gabapentin—epilepsy syndrome	0.000112	0.000483	CcSEcCtD
Methysergide—Nausea—Lamotrigine—epilepsy syndrome	0.000112	0.000482	CcSEcCtD
Methysergide—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000112	0.00048	CcSEcCtD
Methysergide—Paraesthesia—Gabapentin—epilepsy syndrome	0.000111	0.00048	CcSEcCtD
Methysergide—Convulsion—Topiramate—epilepsy syndrome	0.000111	0.000477	CcSEcCtD
Methysergide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000111	0.000477	CcSEcCtD
Methysergide—Dyspnoea—Gabapentin—epilepsy syndrome	0.000111	0.000476	CcSEcCtD
Methysergide—Somnolence—Gabapentin—epilepsy syndrome	0.00011	0.000475	CcSEcCtD
Methysergide—Dyspepsia—Gabapentin—epilepsy syndrome	0.000109	0.00047	CcSEcCtD
Methysergide—Myalgia—Topiramate—epilepsy syndrome	0.000109	0.000469	CcSEcCtD
Methysergide—Chest pain—Topiramate—epilepsy syndrome	0.000109	0.000469	CcSEcCtD
Methysergide—Arthralgia—Topiramate—epilepsy syndrome	0.000109	0.000469	CcSEcCtD
Methysergide—Discomfort—Topiramate—epilepsy syndrome	0.000108	0.000463	CcSEcCtD
Methysergide—Asthenia—Valproic Acid—epilepsy syndrome	0.000107	0.000463	CcSEcCtD
Methysergide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000107	0.000461	CcSEcCtD
Methysergide—Fatigue—Gabapentin—epilepsy syndrome	0.000107	0.000461	CcSEcCtD
Methysergide—Abdominal pain—Pregabalin—epilepsy syndrome	0.000107	0.000461	CcSEcCtD
Methysergide—Body temperature increased—Pregabalin—epilepsy syndrome	0.000107	0.000461	CcSEcCtD
Methysergide—Pain—Gabapentin—epilepsy syndrome	0.000106	0.000457	CcSEcCtD
Methysergide—Constipation—Gabapentin—epilepsy syndrome	0.000106	0.000457	CcSEcCtD
Methysergide—Oedema—Topiramate—epilepsy syndrome	0.000104	0.00045	CcSEcCtD
Methysergide—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000102	0.000441	CcSEcCtD
Methysergide—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000102	0.00044	CcSEcCtD
Methysergide—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000102	0.00044	CcSEcCtD
Methysergide—Tachycardia—Topiramate—epilepsy syndrome	0.000102	0.000439	CcSEcCtD
Methysergide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000102	0.000437	CcSEcCtD
Methysergide—Dizziness—Valproic Acid—epilepsy syndrome	9.9e-05	0.000426	CcSEcCtD
Methysergide—Body temperature increased—Gabapentin—epilepsy syndrome	9.81e-05	0.000422	CcSEcCtD
Methysergide—Abdominal pain—Gabapentin—epilepsy syndrome	9.81e-05	0.000422	CcSEcCtD
Methysergide—Asthenia—Pregabalin—epilepsy syndrome	9.71e-05	0.000418	CcSEcCtD
Methysergide—Vomiting—Valproic Acid—epilepsy syndrome	9.52e-05	0.00041	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	9.52e-05	0.00041	CcSEcCtD
Methysergide—Insomnia—Topiramate—epilepsy syndrome	9.45e-05	0.000407	CcSEcCtD
Methysergide—Rash—Valproic Acid—epilepsy syndrome	9.44e-05	0.000406	CcSEcCtD
Methysergide—Dermatitis—Valproic Acid—epilepsy syndrome	9.43e-05	0.000406	CcSEcCtD
Methysergide—Paraesthesia—Topiramate—epilepsy syndrome	9.38e-05	0.000404	CcSEcCtD
Methysergide—Dyspnoea—Topiramate—epilepsy syndrome	9.31e-05	0.000401	CcSEcCtD
Methysergide—Somnolence—Topiramate—epilepsy syndrome	9.29e-05	0.0004	CcSEcCtD
Methysergide—Diarrhoea—Pregabalin—epilepsy syndrome	9.26e-05	0.000399	CcSEcCtD
Methysergide—Dyspepsia—Topiramate—epilepsy syndrome	9.19e-05	0.000396	CcSEcCtD
Methysergide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	9.02e-05	0.000388	CcSEcCtD
Methysergide—Fatigue—Topiramate—epilepsy syndrome	9.01e-05	0.000388	CcSEcCtD
Methysergide—Dizziness—Pregabalin—epilepsy syndrome	8.95e-05	0.000385	CcSEcCtD
Methysergide—Pain—Topiramate—epilepsy syndrome	8.93e-05	0.000385	CcSEcCtD
Methysergide—Constipation—Topiramate—epilepsy syndrome	8.93e-05	0.000385	CcSEcCtD
Methysergide—Asthenia—Gabapentin—epilepsy syndrome	8.91e-05	0.000383	CcSEcCtD
Methysergide—Nausea—Valproic Acid—epilepsy syndrome	8.9e-05	0.000383	CcSEcCtD
Methysergide—Vomiting—Pregabalin—epilepsy syndrome	8.61e-05	0.000371	CcSEcCtD
Methysergide—Feeling abnormal—Topiramate—epilepsy syndrome	8.61e-05	0.000371	CcSEcCtD
Methysergide—Gastrointestinal pain—Topiramate—epilepsy syndrome	8.54e-05	0.000368	CcSEcCtD
Methysergide—Rash—Pregabalin—epilepsy syndrome	8.54e-05	0.000367	CcSEcCtD
Methysergide—Dermatitis—Pregabalin—epilepsy syndrome	8.53e-05	0.000367	CcSEcCtD
Methysergide—Diarrhoea—Gabapentin—epilepsy syndrome	8.49e-05	0.000366	CcSEcCtD
Methysergide—Abdominal pain—Topiramate—epilepsy syndrome	8.26e-05	0.000355	CcSEcCtD
Methysergide—Body temperature increased—Topiramate—epilepsy syndrome	8.26e-05	0.000355	CcSEcCtD
Methysergide—Dizziness—Gabapentin—epilepsy syndrome	8.21e-05	0.000353	CcSEcCtD
Methysergide—Nausea—Pregabalin—epilepsy syndrome	8.04e-05	0.000346	CcSEcCtD
Methysergide—Vomiting—Gabapentin—epilepsy syndrome	7.89e-05	0.00034	CcSEcCtD
Methysergide—Rash—Gabapentin—epilepsy syndrome	7.83e-05	0.000337	CcSEcCtD
Methysergide—Dermatitis—Gabapentin—epilepsy syndrome	7.82e-05	0.000337	CcSEcCtD
Methysergide—Asthenia—Topiramate—epilepsy syndrome	7.49e-05	0.000323	CcSEcCtD
Methysergide—Nausea—Gabapentin—epilepsy syndrome	7.37e-05	0.000317	CcSEcCtD
Methysergide—Diarrhoea—Topiramate—epilepsy syndrome	7.15e-05	0.000308	CcSEcCtD
Methysergide—Dizziness—Topiramate—epilepsy syndrome	6.91e-05	0.000297	CcSEcCtD
Methysergide—Vomiting—Topiramate—epilepsy syndrome	6.64e-05	0.000286	CcSEcCtD
Methysergide—Rash—Topiramate—epilepsy syndrome	6.59e-05	0.000284	CcSEcCtD
Methysergide—Dermatitis—Topiramate—epilepsy syndrome	6.58e-05	0.000283	CcSEcCtD
Methysergide—Nausea—Topiramate—epilepsy syndrome	6.2e-05	0.000267	CcSEcCtD
Methysergide—HTR7—Signaling Pathways—CCR5—epilepsy syndrome	6.16e-06	3.65e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—NGF—epilepsy syndrome	6.16e-06	3.65e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—RELA—epilepsy syndrome	6.14e-06	3.64e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NTRK2—epilepsy syndrome	6.12e-06	3.63e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCR2—epilepsy syndrome	6.12e-06	3.63e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SST—epilepsy syndrome	6.12e-06	3.63e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CCR5—epilepsy syndrome	6.12e-06	3.63e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—FYN—epilepsy syndrome	6.08e-06	3.61e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—AKT3—epilepsy syndrome	6.08e-06	3.6e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—DUSP6—epilepsy syndrome	6.06e-06	3.6e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—H2AFX—epilepsy syndrome	6.06e-06	3.6e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MEF2C—epilepsy syndrome	6.05e-06	3.59e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—AKT3—epilepsy syndrome	6.04e-06	3.58e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—POMC—epilepsy syndrome	6.04e-06	3.58e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—HTR2A—epilepsy syndrome	6.03e-06	3.58e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—HTR2A—epilepsy syndrome	6.03e-06	3.57e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—MTOR—epilepsy syndrome	6.02e-06	3.57e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—POMC—epilepsy syndrome	6.01e-06	3.56e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CCR5—epilepsy syndrome	5.99e-06	3.55e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—HTR2A—epilepsy syndrome	5.99e-06	3.55e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ADRA2A—epilepsy syndrome	5.99e-06	3.55e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PLAT—epilepsy syndrome	5.96e-06	3.54e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ADAM10—epilepsy syndrome	5.93e-06	3.52e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—CCL2—epilepsy syndrome	5.91e-06	3.5e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ADAM10—epilepsy syndrome	5.9e-06	3.5e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—CCL2—epilepsy syndrome	5.88e-06	3.49e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—HTR2A—epilepsy syndrome	5.86e-06	3.48e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—YWHAZ—epilepsy syndrome	5.85e-06	3.47e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—RELA—epilepsy syndrome	5.79e-06	3.43e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—NGF—epilepsy syndrome	5.78e-06	3.43e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CXCL12—epilepsy syndrome	5.75e-06	3.41e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—BDKRB2—epilepsy syndrome	5.75e-06	3.41e-05	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—POMC—epilepsy syndrome	5.74e-06	3.41e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TSC2—epilepsy syndrome	5.73e-06	3.4e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—PRKCB—epilepsy syndrome	5.73e-06	3.4e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TSC2—epilepsy syndrome	5.72e-06	3.4e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—AGT—epilepsy syndrome	5.72e-06	3.39e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—AGT—epilepsy syndrome	5.72e-06	3.39e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—IL6ST—epilepsy syndrome	5.7e-06	3.38e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TSC2—epilepsy syndrome	5.69e-06	3.37e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—AGT—epilepsy syndrome	5.68e-06	3.37e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—MTOR—epilepsy syndrome	5.68e-06	3.37e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—JUNB—epilepsy syndrome	5.65e-06	3.35e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CNR1—epilepsy syndrome	5.65e-06	3.35e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CCR5—epilepsy syndrome	5.63e-06	3.34e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PLCB1—epilepsy syndrome	5.63e-06	3.34e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—S100B—epilepsy syndrome	5.61e-06	3.33e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—APOE—epilepsy syndrome	5.61e-06	3.33e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—APOE—epilepsy syndrome	5.6e-06	3.32e-05	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—AKT1—epilepsy syndrome	5.59e-06	3.31e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—S100B—epilepsy syndrome	5.58e-06	3.31e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TSC2—epilepsy syndrome	5.57e-06	3.3e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—APOE—epilepsy syndrome	5.57e-06	3.3e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—AGT—epilepsy syndrome	5.56e-06	3.3e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SOCS3—epilepsy syndrome	5.56e-06	3.3e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CDC42—epilepsy syndrome	5.54e-06	3.29e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CASP3—epilepsy syndrome	5.54e-06	3.28e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SOCS3—epilepsy syndrome	5.53e-06	3.28e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CDC42—epilepsy syndrome	5.51e-06	3.27e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—HTR7—epilepsy syndrome	5.51e-06	3.27e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—HTR2A—epilepsy syndrome	5.51e-06	3.27e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—KDR—epilepsy syndrome	5.49e-06	3.26e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—KDR—epilepsy syndrome	5.49e-06	3.26e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—KDR—epilepsy syndrome	5.45e-06	3.23e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—APOE—epilepsy syndrome	5.45e-06	3.23e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—JUN—epilepsy syndrome	5.38e-06	3.19e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—AVP—epilepsy syndrome	5.37e-06	3.18e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—HBEGF—epilepsy syndrome	5.35e-06	3.17e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—AVP—epilepsy syndrome	5.34e-06	3.17e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—KDR—epilepsy syndrome	5.34e-06	3.17e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PRKCB—epilepsy syndrome	5.29e-06	3.14e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PRKCB—epilepsy syndrome	5.28e-06	3.13e-05	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—AKT1—epilepsy syndrome	5.27e-06	3.13e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IL6ST—epilepsy syndrome	5.27e-06	3.12e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IL6ST—epilepsy syndrome	5.26e-06	3.12e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PRKCB—epilepsy syndrome	5.25e-06	3.11e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AKT3—epilepsy syndrome	5.25e-06	3.11e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—MMP9—epilepsy syndrome	5.23e-06	3.1e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TSC2—epilepsy syndrome	5.23e-06	3.1e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IL6ST—epilepsy syndrome	5.23e-06	3.1e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—AGT—epilepsy syndrome	5.22e-06	3.1e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CASP3—epilepsy syndrome	5.22e-06	3.1e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—POMC—epilepsy syndrome	5.22e-06	3.09e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PRKCB—epilepsy syndrome	5.14e-06	3.05e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ADAM10—epilepsy syndrome	5.13e-06	3.04e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—APOE—epilepsy syndrome	5.12e-06	3.04e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IL6ST—epilepsy syndrome	5.12e-06	3.04e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—CCL2—epilepsy syndrome	5.1e-06	3.03e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	5.07e-06	3.01e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—AKT1—epilepsy syndrome	5.07e-06	3.01e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—JUN—epilepsy syndrome	5.07e-06	3.01e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HES1—epilepsy syndrome	5.05e-06	2.99e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—KDR—epilepsy syndrome	5.02e-06	2.97e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	4.93e-06	2.93e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—MMP9—epilepsy syndrome	4.93e-06	2.93e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	4.92e-06	2.92e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—FYN—epilepsy syndrome	4.91e-06	2.91e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	4.91e-06	2.91e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—H2AFX—epilepsy syndrome	4.89e-06	2.9e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MEF2C—epilepsy syndrome	4.88e-06	2.9e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—S100B—epilepsy syndrome	4.85e-06	2.88e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PRKCB—epilepsy syndrome	4.83e-06	2.86e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—SRC—epilepsy syndrome	4.82e-06	2.86e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—POMC—epilepsy syndrome	4.82e-06	2.86e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—POMC—epilepsy syndrome	4.81e-06	2.85e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IL6ST—epilepsy syndrome	4.81e-06	2.85e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SOCS3—epilepsy syndrome	4.8e-06	2.85e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CDC42—epilepsy syndrome	4.79e-06	2.84e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—AKT1—epilepsy syndrome	4.79e-06	2.84e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—POMC—epilepsy syndrome	4.78e-06	2.84e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	4.74e-06	2.81e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—YWHAZ—epilepsy syndrome	4.72e-06	2.8e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CCL2—epilepsy syndrome	4.71e-06	2.8e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CCL2—epilepsy syndrome	4.71e-06	2.79e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—VEGFA—epilepsy syndrome	4.7e-06	2.79e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	4.69e-06	2.78e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—POMC—epilepsy syndrome	4.68e-06	2.78e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CCL2—epilepsy syndrome	4.68e-06	2.77e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NGF—epilepsy syndrome	4.67e-06	2.77e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AVP—epilepsy syndrome	4.64e-06	2.75e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CCL2—epilepsy syndrome	4.58e-06	2.72e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	4.56e-06	2.71e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—SRC—epilepsy syndrome	4.55e-06	2.7e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CCR5—epilepsy syndrome	4.54e-06	2.69e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	4.47e-06	2.65e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HTR2A—epilepsy syndrome	4.44e-06	2.63e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—VEGFA—epilepsy syndrome	4.43e-06	2.63e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—POMC—epilepsy syndrome	4.4e-06	2.61e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—HES1—epilepsy syndrome	4.38e-06	2.6e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CCL2—epilepsy syndrome	4.3e-06	2.55e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—FYN—epilepsy syndrome	4.26e-06	2.53e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—FGF2—epilepsy syndrome	4.26e-06	2.53e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—FGF2—epilepsy syndrome	4.26e-06	2.52e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—H2AFX—epilepsy syndrome	4.25e-06	2.52e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	4.24e-06	2.52e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MEF2C—epilepsy syndrome	4.24e-06	2.51e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	4.24e-06	2.51e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—FGF2—epilepsy syndrome	4.23e-06	2.51e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TSC2—epilepsy syndrome	4.22e-06	2.5e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—AGT—epilepsy syndrome	4.21e-06	2.5e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	4.15e-06	2.46e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—FGF2—epilepsy syndrome	4.14e-06	2.46e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—APOE—epilepsy syndrome	4.13e-06	2.45e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	4.1e-06	2.43e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	4.07e-06	2.41e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	4.05e-06	2.4e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—KDR—epilepsy syndrome	4.05e-06	2.4e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—RELA—epilepsy syndrome	3.95e-06	2.35e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—RELA—epilepsy syndrome	3.95e-06	2.34e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	3.94e-06	2.34e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—RELA—epilepsy syndrome	3.92e-06	2.33e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	3.91e-06	2.32e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	3.9e-06	2.31e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	3.89e-06	2.31e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	3.89e-06	2.31e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	3.88e-06	2.3e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MTOR—epilepsy syndrome	3.88e-06	2.3e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MTOR—epilepsy syndrome	3.87e-06	2.3e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MTOR—epilepsy syndrome	3.85e-06	2.28e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—RELA—epilepsy syndrome	3.84e-06	2.28e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	3.77e-06	2.24e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	3.66e-06	2.17e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	3.66e-06	2.17e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	3.61e-06	2.14e-05	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—AKT1—epilepsy syndrome	3.6e-06	2.14e-05	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—AKT1—epilepsy syndrome	3.6e-06	2.13e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	3.59e-06	2.13e-05	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—AKT1—epilepsy syndrome	3.57e-06	2.12e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CASP3—epilepsy syndrome	3.57e-06	2.12e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	3.57e-06	2.12e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CASP3—epilepsy syndrome	3.56e-06	2.11e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	3.55e-06	2.1e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	3.54e-06	2.1e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	3.54e-06	2.1e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	3.51e-06	2.08e-05	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	3.5e-06	2.07e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	3.49e-06	2.07e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	3.47e-06	2.06e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	3.47e-06	2.06e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—JUN—epilepsy syndrome	3.46e-06	2.05e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—JUN—epilepsy syndrome	3.46e-06	2.05e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	3.44e-06	2.04e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	3.38e-06	2.01e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MMP9—epilepsy syndrome	3.37e-06	2e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	3.37e-06	2e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MMP9—epilepsy syndrome	3.37e-06	2e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	3.37e-06	2e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	3.35e-06	1.98e-05	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	3.29e-06	1.95e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	3.28e-06	1.94e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—AKT1—epilepsy syndrome	3.27e-06	1.94e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—AKT1—epilepsy syndrome	3.27e-06	1.94e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	3.26e-06	1.93e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	3.24e-06	1.92e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	3.18e-06	1.88e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	3.16e-06	1.88e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	3.15e-06	1.87e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	3.14e-06	1.86e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—SRC—epilepsy syndrome	3.11e-06	1.84e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—SRC—epilepsy syndrome	3.1e-06	1.84e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	3.08e-06	1.83e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	3.08e-06	1.83e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	3.08e-06	1.82e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	3.03e-06	1.8e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—VEGFA—epilepsy syndrome	3.02e-06	1.79e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	3.02e-06	1.79e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	3.01e-06	1.79e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	3e-06	1.78e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—AKT1—epilepsy syndrome	3e-06	1.78e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	2.98e-06	1.77e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	2.94e-06	1.74e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	2.93e-06	1.74e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	2.91e-06	1.73e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	2.87e-06	1.7e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	2.86e-06	1.69e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	2.84e-06	1.68e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—AKT1—epilepsy syndrome	2.83e-06	1.68e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	2.76e-06	1.64e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	2.72e-06	1.62e-05	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.66e-06	1.58e-05	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	2.65e-06	1.57e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	2.64e-06	1.57e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	2.63e-06	1.56e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	2.56e-06	1.52e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	2.55e-06	1.51e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	2.53e-06	1.5e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	2.5e-06	1.48e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	2.48e-06	1.47e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	2.48e-06	1.47e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	2.42e-06	1.44e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	2.41e-06	1.43e-05	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.3e-06	1.37e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	2.3e-06	1.36e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	2.29e-06	1.36e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	2.28e-06	1.35e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.24e-06	1.33e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	2.23e-06	1.32e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	2.22e-06	1.31e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	2.16e-06	1.28e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.09e-06	1.24e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	1.99e-06	1.18e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	1.94e-06	1.15e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	1.93e-06	1.15e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—AKT1—epilepsy syndrome	1.93e-06	1.14e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	1.92e-06	1.14e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	1.88e-06	1.11e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	1.76e-06	1.05e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	1.43e-06	8.48e-06	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	1.42e-06	8.44e-06	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	1.24e-06	7.33e-06	CbGpPWpGaD
